{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:37:43Z","timestamp":1761766663085,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic polymorphism can result in abnormal pharmacodynamics that subsequently leads to the individual variance in sedative effects and adverse reactions. The aim of this study was to elucidate the association between midazolam-related genetic polymorphism and sedative effects, including adverse reactions, under conscious sedation during upper gastrointestinal endoscopy. We prospectively enrolled 100 eligible patients undergoing upper gastrointestinal endoscopy. The efficacy of the sedation, adverse reactions, plasma concentration of midazolam and 1-hydroxymidazolam were investigated as well as the genetic polymorphism of <jats:italic>MDR1<\/jats:italic> and <jats:italic>CYP3A5<\/jats:italic>. The correlation between genetic polymorphism and sedative effects was assessed. Regarding <jats:italic>MDR1<\/jats:italic> gene, the plasma concentration of midazolam was greater in patients with CGC haplotype (<jats:italic>P<\/jats:italic>\u2009=\u20090.012), while it was lower in patients with CAC haplotype (<jats:italic>P<\/jats:italic>\u2009=\u20090.005) than in those with other haplotypes. However, genetic polymorphism of neither <jats:italic>MDR1<\/jats:italic> nor <jats:italic>CYP3A5<\/jats:italic> correlated with the plasma concentration of 1-hydroxymidazolam. CGT haplotype of <jats:italic>MDR1<\/jats:italic> was significantly correlated with sedation grade after midazolam administration (<jats:italic>P<\/jats:italic>\u2009=\u20090.042). In contrast, genetic polymorphism of <jats:italic>CYP3A5<\/jats:italic> was not correlated with sedation grade. There was no association between genetic polymorphism of <jats:italic>MDR1<\/jats:italic> or <jats:italic>CYP3A5<\/jats:italic> and selected adverse reactions related to midazolam. Genetic polymorphism of <jats:italic>MDR1<\/jats:italic> influences the concentration of midazolam and the sedation grade. However, it is not associated with adverse reactions such as paradoxical response and retrograde amnesia.<\/jats:p>","DOI":"10.1038\/s41598-019-52517-7","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:12:36Z","timestamp":1572952356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influence of midazolam-related genetic polymorphism on conscious sedation during upper gastrointestinal endoscopy in a Korean population"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-8920","authenticated-orcid":false,"given":"Jae Yong","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"52517_CR1","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/j.1440-1746.2005.04081.x","volume":"20","author":"SY Yi","year":"2005","unstructured":"Yi, S. Y. & Shin, J. E. Midazolam for patients undergoing upper gastrointestinal endoscopy: A prospective, single-blind and randomized study to determine the appropriate amount and time of initiation of endoscopy. J Gastroen Hepatol 20, 1873\u20131879, https:\/\/doi.org\/10.1111\/j.1440-1746.2005.04081.x (2005).","journal-title":"J Gastroen Hepatol"},{"key":"52517_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/0300060513515437","volume":"42","author":"W Wu","year":"2014","unstructured":"Wu, W., Chen, Q., Zhang, L. C. & Chen, W. H. Dexmedetomidine versus midazolam for sedation in upper gastrointestinal endoscopy. J Int Med Res 42, 516\u2013522, https:\/\/doi.org\/10.1177\/0300060513515437 (2014).","journal-title":"J Int Med Res"},{"key":"52517_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3748\/wjg.v19.i4.463","volume":"19","author":"JK Triantafillidis","year":"2013","unstructured":"Triantafillidis, J. K., Merikas, E., Nikolakis, D. & Papalois, A. E. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol 19, 463\u2013481, https:\/\/doi.org\/10.3748\/wjg.v19.i4.463 (2013).","journal-title":"World J Gastroenterol"},{"unstructured":"Lee, S. Y. et al. Identification of factors that influence conscious sedation in gastrointestinal endoscopy. J Korean Med Sci 19, 536\u2013540, doi:D - NLM: PMC2816887 EDAT- 2004\/08\/17 10:00 MHDA- 2005\/08\/05 09:00 CRDT- 2004\/08\/17 10:00 AID - 200408536 [pii] PST - ppublish (2004).","key":"52517_CR4"},{"key":"52517_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/000992289703601202","volume":"36","author":"M Massanari","year":"1997","unstructured":"Massanari, M., Novitsky, J. & Reinstein, L. J. Paradoxical reactions in children associated with midazolam use during endoscopy. Clin Pediatr 36, 681\u2013684, https:\/\/doi.org\/10.1177\/000992289703601202 (1997).","journal-title":"Clin Pediatr"},{"key":"52517_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4097\/kjae.2012.62.4.332","volume":"62","author":"HJ Byon","year":"2012","unstructured":"Byon, H. J. et al. The influence of DNA polymorphism of multidrug resistant 1 (MDR1) on the effect of midazolam pretreatment in children. Korean J Anesthesiol 62, 332\u2013336, https:\/\/doi.org\/10.4097\/kjae.2012.62.4.332 (2012).","journal-title":"Korean J Anesthesiol"},{"key":"52517_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.dld.2014.04.007","volume":"46","author":"CH Tae","year":"2014","unstructured":"Tae, C. H. et al. Paradoxical reaction to midazolam in patients undergoing endoscopy under sedation: Incidence, risk factors and the effect of flumazenil. Dig Liver Dis 46, 710\u2013715, https:\/\/doi.org\/10.1016\/j.dld.2014.04.007 (2014).","journal-title":"Dig Liver Dis"},{"key":"52517_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/0310057X8701500314","volume":"15","author":"TG Short","year":"1987","unstructured":"Short, T. G., Forrest, P. & Galletly, D. C. Paradoxical reactions to benzodiazepines\u2013a genetically determined phenomenon? Anaesth Intensive Care 15, 330\u2013331 (1987).","journal-title":"Anaesth Intensive Care"},{"key":"52517_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0166-0934(97)02178-2","volume":"65","author":"AM Lindberg","year":"1997","unstructured":"Lindberg, A. M., Polacek, C. & Johansson, S. Amplification and cloning of complete enterovirus genomes by long distance PCR. J Virol Methods 65, 191\u2013199 (1997).","journal-title":"J Virol Methods"},{"issue":"Suppl 1","key":"52517_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/den.12024","volume":"25","author":"T Sasaki","year":"2013","unstructured":"Sasaki, T. et al. Recommended sedation and intraprocedural monitoring for gastric endoscopic submucosal dissection. Dig Endosc 25(Suppl 1), 79\u201385, https:\/\/doi.org\/10.1111\/den.12024 (2013).","journal-title":"Dig Endosc"},{"key":"52517_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.gie.2008.09.029","volume":"68","author":"DR Lichtenstein","year":"2008","unstructured":"Lichtenstein, D. R. et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 68, 815\u2013826 (2008).","journal-title":"Gastrointest Endosc"},{"key":"52517_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5946\/ce.2014.47.2.135","volume":"47","author":"SH Moon","year":"2014","unstructured":"Moon, S. H. Sedation regimens for gastrointestinal endoscopy. Clin Endosc 47, 135\u2013140, https:\/\/doi.org\/10.5946\/ce.2014.47.2.135 (2014).","journal-title":"Clin Endosc"},{"key":"52517_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1572-0241.2000.01866.x","volume":"95","author":"SA Fulton","year":"2000","unstructured":"Fulton, S. A. & Mullen, K. D. Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil? Am J Gastroenterol 95, 809\u2013811, https:\/\/doi.org\/10.1111\/j.1572-0241.2000.01866.x (2000).","journal-title":"Am J Gastroenterol"},{"key":"52517_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000138007","volume":"29","author":"RM Arendt","year":"1984","unstructured":"Arendt, R. M., Greenblatt, D. J. & Garland, W. A. Quantitation by gas chromatography of the 1- and 4-hydroxy metabolites of midazolam in human plasma. Pharmacology 29, 158\u2013164 (1984).","journal-title":"Pharmacology"},{"key":"52517_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/01.fpc.0000054118.14659.48","volume":"13","author":"MD Floyd","year":"2003","unstructured":"Floyd, M. D. et al. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics 13, 595\u2013606, https:\/\/doi.org\/10.1097\/01.fpc.0000054118.14659.48 (2003).","journal-title":"Pharmacogenetics"},{"key":"52517_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00008571-200310000-00001","volume":"13","author":"KE Thummel","year":"2003","unstructured":"Thummel, K. E. Does the CYP3A5*3 polymorphism affect in vivo drug elimination? Pharmacogenetics 13, 585\u2013587 (2003).","journal-title":"Pharmacogenetics"},{"key":"52517_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1515\/DMDI.2011.006","volume":"26","author":"A Lazarowski","year":"2011","unstructured":"Lazarowski, A. & Czornyj, L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metabol Drug Interact 26, 21\u201326, https:\/\/doi.org\/10.1515\/DMDI.2011.006 (2011).","journal-title":"Drug Metabol Drug Interact"},{"key":"52517_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1023\/A:1023433502647","volume":"20","author":"S Tolle-Sander","year":"2003","unstructured":"Tolle-Sander, S., Rautio, J., Wring, S., Polli, J. W. & Polli, J. E. Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate. Pharm Res 20, 757\u2013764 (2003).","journal-title":"Pharm Res"},{"key":"52517_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4097\/kjae.2013.65.1.2","volume":"65","author":"YE Moon","year":"2013","unstructured":"Moon, Y. E. Paradoxical reaction to midazolam in children. Korean J Anesthesiol 65, 2\u20133, https:\/\/doi.org\/10.4097\/kjae.2013.65.1.2 (2013).","journal-title":"Korean J Anesthesiol"},{"key":"52517_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jfma.2013.07.018","volume":"114","author":"YH Hsu","year":"2015","unstructured":"Hsu, Y. H. et al. Evident cognitive impairments in seemingly recovered patients after midazolam-based light sedation during diagnostic endoscopy. J Formos Med Assoc 114, 489\u2013497, https:\/\/doi.org\/10.1016\/j.jfma.2013.07.018 (2015).","journal-title":"J Formos Med Assoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52517-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:25:44Z","timestamp":1671290744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52517-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52517"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52517-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16001"}}